Effectiveness of oral cryotherapy in preventing methotrexate-induced oral mucositis in pediatric patients with acute lymphoblastic leukemia: a randomized controlled trial
Supportive Care in Cancer · 2026-09 · 34 (9)
DOI: 10.1007/s00520-026-11075-1 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Supportive Care in Cancer, online erschienen am 14.08.2026. Verfasst von Luyang Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Oncology, Shenzhen Children's Hospital, 7019 Yitian Road, Shenzhen, Guangdong Province, China. Hauptthemen laut MEDLINE: Methotrexate, Stomatitis, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Cryotherapy. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Sanming Project of Medicine in Shenzen Municipality.
Abstract (Originalsprache)
PURPOSE: To evaluate whether oral cryotherapy (OC) using ice-cold saline reduces the incidence and severity of high-dose methotrexate (HD-MTX)-induced oral mucositis (OM) in children with acute lymphoblastic leukemia (ALL). METHODS: This single-center, open-label, parallel-group randomized controlled trial (RCT) enrolled children aged 3-18 years with ALL undergoing consolidation therapy with HD-MTX. Participants were randomly assigned (1:1) to either OC (ice-cold saline oral rinses) or standard oral care alone. HD-MTX was administered at doses of 3 g/m2 or 5 g/m2 over 24 h. The primary outcome was the incidence of OM of any grade (WHO grade ≥ I) within 14 days. Secondary outcomes included OM incidence (WHO grade ≥ II), OM duration, and mucositis-free survival by day 14. The primary analysis was conducted according to the per-protocol (PP) principle and included 118 participants with available outcome data; nine participants were excluded after randomization because of poor compliance (OC, n = 7; control, n = 2). The impact of missing outcome data was assessed using complete intention-to-treat (ITT) worst-case analysis, reference-based imputation, and tipping-point sensitivity analysis. RESULTS: A total of 127 patients were randomized. The primary day 14 analysis included 118 participants with available outcome assessments, with 59 participants in each group. The incidence of any-grade OM was significantly lower in the OC group (22.0% vs. 44.1%; P = 0.019). The incidence of OM of WHO grade ≥ II was also significantly lower in the OC group (6.8% vs. 23.7%; P = 0.021), corresponding to a substantial relative risk reduction. After multivariable adjustment, OC remained associated with a lower OM risk (adjusted odds ratio [OR], 0.37; 95% confidence interval [CI], 0.16-0.85; adjusted Cox hazard ratio [HR], 0.42; 95% CI, 0.21-0.84). The results of the reference-based imputation analysis were consistent with those of the primary analysis. However, OM duration did not differ significantly between groups (4.00 vs. 5.00 days; P = 0.318). Subgroup analyses revealed that the protective effect of OC was most pronounced in children older than 6 years (HR 0.25; P for interaction = 0.046) and those receiving MTX at 5 g/m2 (HR 0.22; P for interaction = 0.038). No serious OC-related adverse events were observed. CONCLUSIONS: OC using ice-cold saline effectively reduces the day 14 incidence and severity of HD-MTX-induced OM and improves mucositis-free survival in pediatric ALL. These findings were supported by the reference-based imputation analysis. This intervention appears to be safe and feasible; however, confirmation through ITT analyses and multicenter trials using age-stratified randomization is required before its routine clinical implementation. TRIAL REGISTRATION: ChiCTR2300078327.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology and Oncology, Shenzhen Children's Hospital, 7019 Yitian Road, Shenzhen, Guangdong Province, China.
- Department of Hematology and Oncology, Shenzhen Children's Hospital, 7019 Yitian Road, Shenzhen, Guangdong Province, China. yinyan0915@sina.com.
Förderung
- Sanming Project of Medicine in Shenzen Municipality
Zitieren
APA
Zhang, L., Wang, C., Patil, S., Luo, Y., Liu, X., Long, X., & Yin, Y. (2026). Effectiveness of oral cryotherapy in preventing methotrexate-induced oral mucositis in pediatric patients with acute lymphoblastic leukemia: a randomized controlled trial. Supportive Care in Cancer, 34(9). https://doi.org/10.1007/s00520-026-11075-1
Vancouver
Zhang L, Wang C, Patil S, Luo Y, Liu X, Long X, et al. Effectiveness of oral cryotherapy in preventing methotrexate-induced oral mucositis in pediatric patients with acute lymphoblastic leukemia: a randomized controlled trial. Supportive Care in Cancer. 2026;34(9). doi:10.1007/s00520-026-11075-1
BibTeX
@article{Zhang2026,
author = {Zhang, Luyang and Wang, Chunyan and Patil, Sandip and Luo, Yuan and Liu, Xiaona and Long, Xianping and Yin, Yan},
title = {Effectiveness of oral cryotherapy in preventing methotrexate-induced oral mucositis in pediatric patients with acute lymphoblastic leukemia: a randomized controlled trial},
journal = {Supportive Care in Cancer},
year = {2026},
volume = {34},
number = {9},
doi = {10.1007/s00520-026-11075-1}
}
EUVIMED